3D Cell Culture Market - Global Industry Insights,
Trends, Outlook, and Opportunity Analysis, 2018-2026
3D cell culture is group of biological cells that are allowed to grow in artificial media in all
three dimensions. It is used in drug discovery and tissue engineering, owing to their property of
providing predictive data for in vivo tests and physiologically relevant information. 3D cell
cultures have more stability and longer lifespan as compared to 2D cell culture system, which
makes them suitable for long term studies long term effects of the drug on cells. 3D cell culture
systems are mostly grown in bioreactors or 3D cell colonies. Studies have reported that they
function similar to natural cells due to which they have applications in cancer research.
Increasing adoption of 3D cell culture by cancer research organizations is expected to drive
growth of 3D cell culture market
High prevalence of various types of cancers and the need for affordable and effective treatment
are the major factor driving growth of the 3D cell culture system market. For instance,
according to the data published by World Health Organization (WHO), cancer accounted for 8.8
million of deaths worldwide in 2015. Increasing investment in healthcare, development of
optimized 3D assays, R&D, and other research related activities are also fuelling growth of 3D
cell culture market. The 3D cultures is majorly used for testing efficiency of new drug
molecule, which can be used for treatment of chronic diseases. This increases adoption of 3D
cell culture by pharmaceuticals and biotechnology industries, which in turn is driving growth of
3D cell culture market.
Request Sample Copy of Research Report:
https://www.coherentmarketinsights.com/insight/request-sample/534
Increasing investment by government and private companies in novel drug discovery is expected
to drive growth of 3D cell culture market in Asia Pacific
Regional segmentation of 3D cell culture market by Coherent Market Insights comprises North
America, Latin America, Europe, Asia Pacific, Africa, and Middle East. Advances in drug
discovery is the major factor driving growth of the market in Asia Pacific region. Increasing